{"id":"W1990643914","doi":"10.1159/000200800","title":"Health-Related Quality of Life in Patients with Hormone Refractory Prostate Cancer Receiving Gefitinib","year":2009,"lang":"en","type":"article","venue":"Urologia Internationalis","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gefitinib; Prostate cancer; Quality of life (healthcare); Antiandrogen; Internal medicine; Oncology; Prostate-specific antigen; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005908182,0.0002339674,0.000676465,0.0004465824,0.0003495071,0.0004473284,0.0001691173,0.0003087737,0.0009205767],"category_scores_gemma":[0.001491754,0.0000902655,0.0004500579,0.0005436075,0.0001877546,0.0003179089,0.0002380768,0.0003587789,0.00008363589],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004119791,"about_ca_system_score_gemma":0.0002826947,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001680234,"about_ca_topic_score_gemma":0.002689868,"domain_scores_codex":[0.999642,0.000130635,0.00002873438,0.00004207214,0.00007601669,0.00008050845],"domain_scores_gemma":[0.9994962,0.0001098502,0.0001972846,0.000009674978,0.00004004679,0.0001469183],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002501103,0.0004948105,0.9722708,0.0001368052,0.0003599263,0.0003537148,0.0002680315,0.0003953291,0.0009490794,0.00001789072,0.0004329083,0.02181951],"study_design_scores_gemma":[0.00009414183,0.0018415,0.9964967,0.00001270121,0.0001047763,0.0005740143,0.0001111954,0.00031275,0.0001203315,0.00001817498,0.0003052593,0.000008466367],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980474,0.001328708,0.00003374838,0.00007133,0.000007636673,0.0000140376,0.00009806678,0.000003640354,0.0003954863],"genre_scores_gemma":[0.9995791,0.0001725407,0.00003373401,0.00002940593,0.000009702615,0.000008843013,0.0001085291,4.484754e-7,0.00005769449],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001680234,"threshold_uncertainty_score":0.00334096,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03388270765459418,"score_gpt":0.3426279617188834,"score_spread":0.3087452540642893,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}